Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+9.18%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$13.6B
AUM Growth
+$810M
(+6.3%)
Cap. Flow
-$188M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
18.01%
Holding
2,079
New
621
Increased
405
Reduced
427
Closed
580
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$200M |
| 2 |
Charles River Laboratories
CRL
|
$163M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$87.8M |
| 4 |
Medtronic
MDT
|
$86.1M |
| 5 |
Keurig Dr Pepper
KDP
|
$78.9M |
Top Sells
| 1 |
Alibaba
BABA
|
$189M |
| 2 |
Boston Scientific
BSX
|
$144M |
| 3 |
Procter & Gamble
PG
|
$139M |
| 4 |
EPAM Systems
EPAM
|
$109M |
| 5 |
Fidelity National Information Services
FIS
|
$78M |
Sector Composition
| 1 | Healthcare | 27.56% |
| 2 | Consumer Discretionary | 16.53% |
| 3 | Financials | 11.61% |
| 4 | Technology | 11.05% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Grupo Aeroportuario del Sureste
ASR
$9.97B
| – | – |
-29,551
| Closed | -$3.32M |
|
1977
ASE Group
ASX
$22.3B
| – | – |
-116,502
| Closed | -$529K |
|
1978
A10 Networks
ATEN
$1.28B
| – | – |
-44,090
| Closed | -$300K |
|
1979
Autohome
ATHM
$3.38B
| – | – |
-106,731
| Closed | -$8.06M |
|
1980
Aurinia Pharmaceuticals
AUPH
$1.6B
| – | – |
-18,740
| Closed | -$303K |
|
|
AUTL
1981
Autolus Therapeutics
AUTL
$381M
| – | – |
-13,672
| Closed | -$220K |
|
1982
Grupo Aval
AVAL
$3.87B
| – | – |
-149,265
| Closed | -$651K |
|
1983
AeroVironment
AVAV
$11.5B
| – | – |
-37,346
| Closed | -$2.97M |
|
1984
Avnet
AVT
$4.42B
| – | – |
-13,098
| Closed | -$365K |
|
1985
Avery Dennison
AVY
$13B
| – | – |
-39,523
| Closed | -$4.51M |
|
|
AXDX
1986
DELISTED
Accelerate Diagnostics
AXDX
| – | – |
-11,174
| Closed | -$1.69M |
|
1987
Axogen
AXGN
$722M
| – | – |
-87,351
| Closed | -$807K |
|
1988
American Axle
AXL
$713M
| – | – |
-254,683
| Closed | -$1.94M |
|
1989
AstraZeneca
AZN
$254B
| – | – |
-145,242
| Closed | -$7.68M |
|
1990
AZZ Inc
AZZ
$3.44B
| – | – |
-56,501
| Closed | -$1.94M |
|
1991
BancFirst
BANF
$4.47B
| – | – |
-66,393
| Closed | -$2.69M |
|
1992
Brink's
BCO
$4.73B
| – | – |
-98,426
| Closed | -$4.48M |
|
1993
BioCryst Pharmaceuticals
BCRX
$1.72B
| – | – |
-50,277
| Closed | -$239K |
|
1994
Barclays
BCS
$70.2B
| – | – |
-127,874
| Closed | -$724K |
|
1995
Belden
BDC
$5.09B
| – | – |
-21,055
| Closed | -$685K |
|
1996
Black Diamond Therapeutics
BDTX
$160M
| – | – |
-8,007
| Closed | -$338K |
|
1997
Bread Financial
BFH
$3.11B
| – | – |
-161,790
| Closed | -$5.83M |
|
1998
BGC Group
BGC
$4.76B
| – | – |
-183,075
| Closed | -$502K |
|
1999
Bausch Health
BHC
$2.65B
| – | – |
-135,716
| Closed | -$2.48M |
|
2000
Benchmark Electronics
BHE
$1.43B
| – | – |
-18,552
| Closed | -$401K |
|